Management of Rosuvastatin Discontinuation

Immediate Discontinuation (Absolute Indications)

Patients should stop rosuvastatin immediately when any of the following high‑risk conditions are present, as recommended by the American College of Cardiology. 1

Temporary Discontinuation Protocol (Mild‑to‑Moderate Symptoms)

For patients with less severe muscle complaints, the American College of Cardiology advises a structured temporary hold and assessment. 1

Non‑Statin Lipid‑Lowering Options for Statin‑Intolerant Patients

When rechallenge fails, adjunctive or alternative therapies are recommended by recent drug‑therapy guidance. 2

Special Considerations in Elderly Patients (≥ 75 years)

The American Geriatrics Society outlines individualized decisions based on functional status and therapeutic goals. 3

Peri‑operative Management

The European Society of Cardiology recommends maintaining rosuvastatin when feasible to avoid rebound lipid elevations. 4

Safety Monitoring After Any Change

Key monitoring steps are emphasized by the American College of Cardiology. 1

Avoiding Common Pitfalls

Evidence from the American College of Cardiology highlights practices that reduce unnecessary discontinuation. [1][5]

Statin Discontinuation Guidelines

Introduction to Statin Discontinuation

• The American College of Cardiology recommends that statins should generally not be discontinued abruptly without a compelling medical indication, as discontinuation—particularly after acute cardiovascular events—is associated with increased cardiovascular morbidity and mortality 6

Conditions for Discontinuation

• Discontinue the statin immediately in patients with severe muscle symptoms, such as unexplained severe muscle pain, tenderness, weakness, or fatigue, with concern for rhabdomyolysis 6
• Discontinue the statin immediately in patients with CK elevation >10 times upper limit of normal (ULN) in the presence of muscle soreness, tenderness, or pain 7, 8

Temporary Discontinuation

• Temporarily discontinue the statin in patients with mild to moderate muscle symptoms until symptoms can be evaluated 6, 9
• Evaluate patients with muscle symptoms for other conditions that increase muscle symptom risk, such as hypothyroidism, reduced renal or hepatic function, rheumatologic disorders, vitamin D deficiency, and primary muscle diseases 6, 7, 8

Reinitiation Protocol

• Wait for complete symptom resolution and CK normalization, typically within 2 weeks to 2 months, before reinitiating the statin 7, 8, 10
• Rechallenge with the same statin at a lower dose or try a different statin with lower myopathy risk 6, 9, 10

Special Considerations

• The American College of Cardiology recommends continuing statins in elderly patients (≥75 years) with secondary prevention (established cardiovascular disease) and good functional status, but considering discontinuation in those with primary prevention only, limited life expectancy, functional decline, frailty, or multimorbidity with polypharmacy 11

Risk Factors

• Patients at higher risk for statin-associated myopathy, such as advanced age (especially >80 years), small body frame, frailty, multisystem disease, and polypharmacy, require more careful monitoring 7, 8, 11

Monitoring

• Obtain baseline history of muscle symptoms before any statin therapy to avoid unnecessary discontinuation 6, 10
• Document the specific reason for discontinuation to guide future management 6
• Do not permanently discontinue without establishing causality or attempting rechallenge 10